Souhaitez-vous accéder aux communiqués récents ?

Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) opened a new research and development facility at adMare BioInnovations’ M4 Innovation Centre, expanding the home of...

Louvain-La-Neuve, Belgium, June 30, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy...

Delray Beach, FL , June 26, 2026 (GLOBE NEWSWIRE) -- The global Laboratory Information Management Systems (LIMS) market is projected to grow from USD 2.88 billion in 2025 to USD 5.19 billion by...

TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- The Research Team at Hennick Humber Hospital (HHH) has been awarded a major research grant from the Canadian Institutes of Health Research (CIHR) as part...

Cosmos Health advances its wholly owned CCX0722 hydrogel weight management patent application across the U.S., Europe, Australia, and Canada.

Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent...

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate at WCID

Prometheuz Introduces Online Testosterone Replacement Therapy Platform for U.S. Men Experiencing Low Testosterone

New York, USA, June 24, 2026 (GLOBE NEWSWIRE) -- Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight The HPV vaccines market is witnessing significant growth due to...

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no...